AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 23, 2019 at 10:12 AM.

  1. #1 cafead, Aug 23, 2019 at 10:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,989
    Likes Received:
    3
    via AstraZeneca PLC AZN announced that its partner FibroGen China has received the second marketing approval for roxadustat in China. This time, the Chinese regulatory authority has granted a nod to roxadustat for the treatment of anaemia caused by chronic kidney disease (CKD) in non-dialysis-dependent (NDD) patients.

    article source
     
    Quote

Reply to Thread